Prognostic value of partial genetic instability in Neuroblastoma with ≤ 50% neuroblastic cell content.

Article English OPEN
Piqueras , Marta; Navarro , Samuel; Cañete , Adela; Castel , Victoria; Noguera , Rosa;

International audience; Aims. Better understanding of neuroblastoma genetics will improve with genome-wide techniques. However it is not adequated to perform these analyses in samples with less than 60% neuroblastic cell content. We evaluated the utility of FISH on tiss... View more
  • References (18)
    18 references, page 1 of 2

    1. Heck JE, Ritz B, Hung RJ, Hashibe M, Boffetta P. The epidemiology of neuroblastoma: a review. Paediatr Perinat Epidemiol 2009;23;125-143.

    2. Bowen KA, Chung DH. Recent advances in neuroblastoma. Curr Opin Pediatr 2009;21;350-356.

    3. Van Roy N, De Preter K, Hoebeeck J et al. The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy. Genome Med 2009;1;74.

    4. Cohn SL, Pearson AD, London WB et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 2009;27;289-297.

    5. Attiyeh EF, London WB, Mosse YP et al. Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med 2005;353;2243-2253.

    6. Maris JMF,Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet 2007;369;2106-2120.o

    7. Janoueix-Lerosey I, Schleiermacher G, Michels E et al. Overall genomic pattern is a predictor of outcome rin neuroblastoma. J Clin Oncol 2009;27;1026-1033.

    8. Ambros PF, Ambros IM, Brodeur GM et al. International consensus for neuroblastoma molecular diaPgnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer 2009;100;1471-1482.

    9. Schleiermacher G, Micheon J, Huon I et al. Chromosomal CGH identifies e patients with a higher risk of relapse in neuroblastoma without MYCN amplification. Br J Cancer 2007;97;238-246.

    10. Villamon E, Piqueras M, Mrackintosh C et al. Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma. Virchows Arch 2008;453;47R-55.

  • Related Organizations (1)
  • Metrics
Share - Bookmark